TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/03/2026
Voltar para busca
Dado oficial do USPTO
THORACOFLO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
22/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
03/07/2019
Data de registro
29/09/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/09/2020
Última transação
22/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
FITZSIMONS, MICHAEL R
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Vascutek Limited
Representantes
Megan E. Fink Bodman PLC
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Surgicalmedicaldental and veterinary apparatus and instruments; artificial vascular graftsartificial stent graftsartificial thoracicthoracoabdominal and abdominal stent graftssurgical hybrid stent graft for treatment of thoracoabdominal aortic aneurysmsstentspatches for repair and reconstruction of internal tissuevascular prostheses; surgical implants comprising artificial materials; suture materials; grafts made primarily of artificial materials being patches for repair and reconstruction of internal tissue; implantable medical systems comprised of artificial endovascular stent grafts; implantable medical devices namelyartificial endovascular stent grafts; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials namelyartificial endovascular graftsartificial endovascular grafts; medical systemssystems for use in artificial organ support; medical devices for measuring blood sugar for medical purposes; surgical systems namely stent delivery systems; surgical devices; devices comprising an artificial vascular graft and a stent; devices comprising an artificial vascular grafta stent and a delivery system; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in thoracoabdominal procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in aortic arch procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in endovascular procedures; thoracic stents; artificial thoracic stent grafts; thoracoabdominal stents; artificial thoracoabdominal stent grafts; artificial stent grafts; artificial stent graft systems; artificial stent graft devices; artificial stent graft systems and surgical devices comprising more than one component; artificial stent graft systems and surgical devices comprising components of more than one stent graft; artificial stent graft systems and surgical devices comprising components of more than one type of stent graft; devices comprising an artificial graft and stent joined together and compacted into a delivery system; artificial thoracic stent graft systems; artificial thoracic stent graft devices; artificial thoracoabdominal stent graft systems; artificial thoracoabdominal stent graft devices; delivery systems for artificial stents and grafts; delivery systems for artificial stent graft systems and artificial stent graft devices; medical systemsminimally invasive devices for aneurysm repair; medical devicesminimally invasive devices for aneurysm repair; medical systemsminimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; medical devicesminimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; cardiac valves for surgical prostheses; cardiac valve replacement systems namelyartificial cardiac valves; artificial heart valves; artificial heart valve conduits; artificial cardiac patches; artificial vascular patches; parts and fittings for all of the aforementioned goods
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/03/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/09/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/02/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/01/2021
FIMP
FINAL DISPOSITION PROCESSED
22/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
29/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/07/2020
PUBO
PUBLISHED FOR OPPOSITION
14/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/05/2020
RFNT
REFUSAL PROCESSED BY IB
14/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/11/2019
RFRR
REFUSAL PROCESSED BY MPU
22/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2019
CNRT
NON-FINAL ACTION WRITTEN
31/10/2019
MAFR
APPLICATION FILING RECEIPT MAILED
22/10/2019
DOCK
ASSIGNED TO EXAMINER
18/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/10/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THORACOFLO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.